APA (7th ed.) Citation

Kim, S. B., Lee, M. S., Song, I. H., Park, H. S., & Kim, S. E. (2023). Theranostic Surrogacy of [123I]NaI for Differentiated Thyroid Cancer Radionuclide Therapy. Molecular pharmaceutics, 20(7), 3460-3470. https://doi.org/10.1021/acs.molpharmaceut.3c00073

Chicago Style (17th ed.) Citation

Kim, Su Bin, Min Seob Lee, In Ho Song, Hyun Soo Park, and Sang Eun Kim. "Theranostic Surrogacy of [123I]NaI for Differentiated Thyroid Cancer Radionuclide Therapy." Molecular Pharmaceutics 20, no. 7 (2023): 3460-3470. https://doi.org/10.1021/acs.molpharmaceut.3c00073.

MLA (9th ed.) Citation

Kim, Su Bin, et al. "Theranostic Surrogacy of [123I]NaI for Differentiated Thyroid Cancer Radionuclide Therapy." Molecular Pharmaceutics, vol. 20, no. 7, 2023, pp. 3460-3470, https://doi.org/10.1021/acs.molpharmaceut.3c00073.